FDA Adverse Event
Malfunction
Summary report: N
INFINITY BIOLOGIX TAQPATH SARS-COV-2 ASSAY
MDR report key: 11593478
·
Received March 30, 2021
Report
- Report Number
- 3017938466-2021-00020
- Event Type
- Malfunction
- Date Received
- March 30, 2021
- Date of Event
- October 8, 2020
- Report Date
- March 30, 2021
- Manufacturer
- INFINITY BIOLOGIX, LLC
- Product Code
- QJR
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
ORIGINAL TEST DATA REVIEWED AND WAS DETERMINED TO BE CONSISTENT WITH REPORTED RESULT. NO ADDITIONAL ANALYSIS OR INVESTIGATION NEEDED BASED ON DISTRIBUTOR ACTION RECENT LITERATURE HAS DEMONSTRATED THAT SALIVA BASED TESTING METHODS ARE MORE ACCURATE AND MORE SENSITIVE THAN THE NASAL SWAB. REFERENCE: OMER SB, SIMONOV M, WARREN JL, ET AL. SALIVA OR NASOPHARYNGEAL SWAB SPECIMENS FOR DETECTION OF SARS-COV-2. THE NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1283-1286. DOI:10.1056/NEJMC2016359.
Description of Event or Problem · 1
PATIENT TOOK A LABCORP ANTIBODY TEST WHICH CAME BACK NEGATIVE. THIS IS HISTORIC COMPLAINT. SUBMISSION INITIALLY SUBMITTED VIA E-MAIL IN ABSENCE OF EMDR REPORTING NOT SETUP.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 490502 | INFINITY BIOLOGIX TAQPATH SARS-COV-2 ASSAY | TAQPATH SARS-COV-2 ASSAY | QJR | INFINITY BIOLOGIX, LLC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |